Skeletal status of men with early and late ankylosing spondylitis

American Journal of Medicine

Volumn 103, Issue 3, 1997, Pages 233-241

  Lee, Y S Lynda ^a   Schlotzhauer, Tammi ^a,b   Ott, Susan M ^c   Van Vollenhoven, Ronald F ^a   Hunter, John ^c   Shapiro, Jay ^d   Marcus, Robert ^a,e   McGuire, James L ^f  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF ROCHESTER SCHOOL OF MEDICINE AND DENTISTRY   (United States)

^c UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e VA PALO ALTO HEALTH CARE SYSTEM   (United States)

^f MOUNT AUBURN HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM; HYDROXYPROLINE; OSTEOCALCIN; PARATHYROID HORMONE;

ADULT; ANKYLOSING SPONDYLITIS; ARTICLE; BONE BIOPSY; BONE DENSITY; BONE METABOLISM; BONE MINERAL; BONE TURNOVER; CLINICAL ARTICLE; CREATININE CLEARANCE; DUAL ENERGY X RAY ABSORPTIOMETRY; HUMAN; ILIAC CREST; LUMBAR SPINE; MALE; OSTEOPENIA; PRIORITY JOURNAL; URINARY EXCRETION;

ABSORPTIOMETRY, PHOTON; BONE AND BONES; BONE DENSITY; CALCIUM; DENSITOMETRY, X-RAY; HUMANS; HYDROXYPROLINE; MALE; OSTEOCALCIN; SEVERITY OF ILLNESS INDEX; SPONDYLITIS, ANKYLOSING; TIME FACTORS;

EID: 0030767444     PISSN: 00029343     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9343(97)00143-5     Document Type: Article

References (43)

1. Carette S, Graham D, Little H, et al. The natural disease course of ankylosing spondylitis. Arthritis Rheum. 26:1983;186.
2. Resnick D, Niwayama G. Ankylosing spondylitis. Resnick D, Niwayama G. Diagnosis of Bone and Joint Disorders. 1988;1103 WB Saunders Co, Philadelphia.
3. Hunter T, Dubo HI. Spinal fractures complicating ankylosing spondylitis: a long-term followup study. Arthritis Rheum. 26:1983;751-759.
4. Murray GC, Persellin RH. Cervical fracture complicating ankylosing spondylitis: a report of eight cases and review of the literature. Am J Med. 70:1981;1033-1042.
5. Trent G, Armstrong GWD, O'Neil J. Thoracolumbar fractures in ankylosing spondylitis: high-risk injuries. Clin Orthop Rel Res. 227:1988;61-66.
6. Stewart AF, Adler M, Byers CM, et al. Calcium homeostasis in immobilization: an example of resorptive hypercalciuria. NEJM. 306:1982;1136-1140.
7. Reid DM, Nicoll JJ, Kennedy NJS. Bone mass in ankylosing spondylitis. J Rheumatology. 13:1986;932-935.
8. Hanson CA, Shagrin JW, Duncan H. Vertebral osteopenia in ankylosing spondylitis. Clin Orthop Rel Res. 74:1971;59-64.
9. Mullaji AB, Upadhyay SS, Ho EK. Bone mineral density in ankylosing spondylitis. DEXA comparison of control subjects with mild and advanced cases. J Bone Joint Surg. 76:1994;660-665.
10. Genant HK, Cann CE. Vertebralmineral determination using quantitative computed tomography.In Deluca H, Frost H, Jee W, et al, eds. Osteoporosis: RecentAdvances in Pathogenesis and Treatment. University Park Press:Baltimore, 1981.
11. Devogelaer J-P, Maldague B, Malghem J, Nagant de Deuchaisnes C. Appendicular and vertebral bone mass in ankylosing spondylitis. Arth Rheum. 1992;1062-1067.
12. Goie the HS, Steven MM, van der Linden SM, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis: A comparison of Rome, New York, and Modified New York Criteria in patients with a positive clinical history screening test for ankylosing spondylitis. Br J Rheum. 24:1985;242-249.
13. Moll JMH, Liyanage SP, Wright V. An objective clinical method to measure lateral spinal flexion. Rheum Phys Med. 11:1972;225.
14. Hart Fd, Strickland D, Cliffe P. Measurement of spinal mobility. Ann Rheum Dis. 33:1974;136.
15. Fries JF, Spit PW, Young DY. The dimensions of health outcomes: the Health Assessment Questionnaire, disability and pain scales. J Rheumatol. 9:1982;789-793.
16. Genant HK, Cann CE, et al. Vertebral mineral determination by quantitative CT: Clinical feasibility and normative data. J Comput Assist Tomogr. 7:1983;554.
17. Snow-Harter C, Whalen R, Myburgh K, et al. Bone mineral density, muscle strength, and recreational exercise in men. J Bone Min Res. 7:1992;1291-1296.
18. Kelly TL. Bone mineral density reference databases for american men and women. J Bone Min Res. 5:(suppl 2):1990;5249.
19. Myburgh KH, Zhou LJ, Steele CR, et al. In vivo assessment of forearm bone mass and ulnar bending stiffness in healthy men. J Bone Min Res. 7:1992;1345-1350.
20. Daltroy LH, Larson MG, Roberts WN, Liang MH. A modification of the health assessment questionnaire for the spondyloarthropathies. J Rheum. 17:1990;946-950.
21. Parfitt AM, Drezner MK, Glorieux FH, et al. 1987 Bone histomorphometry nomenclature, symbols and units report of the ASBMR histomorphometry committee. J Bone Min Res. 2:1987;595-610.
22. Malluche HH, Faugere MC. Atlas of Mineralized Bone Histology. 1986;Karger, New York.
23. Recker RR, Kimmel DB, Parfitt AM, et al. Static and tetracycline-based bone histomorphometric data from 34 normal postmenopausal females. J Bone Min Res. 3:1988;133-144.
24. Foldes J, Parfitt AM, Shih M-S, et al. Structural and geometric changes in iliac bone: relationship to normal aging and osteoporosis. J Bone Min Res. 6:1991;759-766.
25. Parisien M, Silverberg SJ, Shane E, et al. The histomorphometry of bone in primary hyperparathyroidism: preservation of cancellous bone structure. J Clin Endocrinol Metab. 70:1990;930-938.
26. Vedi S, Compston JE, Webb A, Tigh JR. Histomorphometric analysis of bone biopsies from the iliac crest of normal British subjects. Metab Bone Dis Rel Res. 4:1982;231-236.
27. Compston JE, Mellish RWE, Croucher P, et al. Structural mechanisms of trabecular bone loss in man. Bone and Mineral. 6:1989;339-350.
28. Aaron JE, Makins NB, Sagreiya K. The microanatomy of trabecular bone loss in normal aging men and women. Clin Orthop Rel Res. 215:1987;260-271.
29. Cheema C, Grant BF, Marcus R. Effect of estrogen on circulating "free" and total 1,25-dihydroxyvitamin D and on the parathyroid-vitamin D axis in postmenopausal women. J Clin Invest. 83:1989;537-542.
30. Packer E, Holloway L, Newhall K, et al. Effects of estrogen on daylong circulating calcium, phosphorus, 1,25-dihydroxyvitamin D, and parathyroid hormone in postmenopausal women. J Bone Min Res. 5:1990;877-884.
31. Marcus R, Madvig P, Young G. Age-related changes in parathyroid hormone and parathyroid hormone action in normal humans. J Clin Endocrinol Metab. 58:1984;223-230.
32. Will R, Palmer R, Bhalla A, et al. Osteoporosis in early ankylosing spondylitis: a primary pathological event? Lancet. 2:1989;1483-1489.
33. Spencer DG, Park WM, Dick HM, et al. Radiological manifestations in 200 patients with ankylosing spondylitis: correlation with clinical features and HLA B27. J Rheum. 6:1979;305-315.
34. Graham B, van Petegheim K. Fractures of the spine in ankylosing spondylitis. Spine. 14:1989;8.
35. Ralston SH, Urquhart DK, Brzeski M, Sturrosk RD. Prevalence of vertebral compression fractures due to osteoporosis in ankylosing spondylitis. BMJ. 300:1990;563-565.
36. Ross PD, Davis JW, Vogel JM, et al. A critical review of bone mass and the risk of fractures in osteoporosis. Calcif Tissue Int. 46:1990;149.
37. Devogelaer JP, Maldague B, Malghem J, de Deuxchaisnes CN. Appendicular and Vertebral bone mass in ankylosing spondylitis. Arthritis Rheum. 35:1992;9.
38. Singh A, Bronson W, Walker SE, Allen SH. Relative value of femoral and lumbar bone mineral density assessments in patients with ankylosing spondylitis. South Med J. 88:1995;939-943.
39. Russel AS, Jackson F. Computer-assisted tomography of the apophyseal changes in patients with ankylosing spondylitis. J Rheum. 13:1986;581.
40. Pacifici R, Rifas L, McCracken R, et al. Ovarian steroid treatment blocks a postmenopausal increase in blood monocyte interleukin-1 release. Proc Natl Acad Sci. 86:1989;2398-2402.
41. Stern PH, Krieger NS, Nissenson RA, et al. Human transforming growth factor alpha stimulates bone resorption in vitro. J Clin Invest. 76:1985;2016-2020.
42. Tashjian AH, Voelkel EF, Levine L, et al. Evidence that the bone resorption stimulating factor produced by mouse fibrosarcoma cells is prostaglandin E2: a new model for hypercalcemia of cancer. J Exp Med. 136:1972;1329-1343.
43. 2m: an animal model of HLA-B27-associated human disorders. Cell. 63:1990;1099-1112.